Increases in osteoid volume with sodium fluoride, calcium, and vitamin D treatment are well documented. Small decreases in mineralisation rate have also been reported.2 But osteomalacia in the presence of high plasma 25-OHD concentrations has not been described in patients treated with this regimen. The plasma 1,25-(OH)2D3 concentration in our patient was just below the lower limit of normal, but the total plasma 1,25-(OH)2D (1,25-(OH)2D2-+1,25-(OH)2D3) concentration was probably normal since she was taking vitamin D2 and the radioimmunoassay did not measure plasma 1,25-(OH)2D2.
Prospective study of effect of fenclofenac on thyroid function tests
The observation of a very low serum thyroxine concentration in a clinically euthyroid patient receiving fenclofenac suggested that this phenylacetic acid group anti-inflammatory agent may displace thyroxine from its binding sites. To test this hypothesis a group of patients about to be given fenclofenac for rheumatoid arthritis were studied.
Patients, methods, and results
Blood samples were taken from seven euthyroid female patients before starting treatment (day 1) and at midday on days 2, 4, 7, and 14. Each sample was analysed for total serum thyroxine (T4) and triiodothyronine (T3) concentrations by radioimmunoassay and for free serum T4 and T3 concentrations by an equilibrium dialysis method.' A thyroid hormone binding test (Thyopac 3) was also done and a derived free thyroxine index calculated.
At midday on days 1, 2, and 14 200-jug thyrotrophin releasing hormone (TRH) tests were performed. Fenclofenac 600 mg was taken at 6 pm on day 1 and at 8 am and 6 pm thereafter. There had been no change in drug treatment immediately before the study and no other drugs known to interfere with thyroid function tests were being given during the study.
The mean total T4 concentration fell rapidly to 24 nmol/l (1 86 jug/100 ml) and the total serum T3 concentration fell similarly but to only about half of the initial value (figure). The Thyopac 3 test result suggested that the (11-6-33-5 pmol/l (0-90-2-60 ng/100 ml)).
The free serum T3 concentration fell from 5-5 to 4 0 pmol/l (350-260 pg/100 ml) (p=0 05) but remained within the normal range of 3 7-7-0 pmol/l (0 24-0-46 pg/100 ml). The thyrotrophin response to TRH was blunted 18 hours after the start of treatment (p=0005) and was still depressed on day 14 (p=001).
Comment
This study shows that fenclofenac rapidly depresses the total serum T4 concentration and, to a lesser extent, total serum T3. The magnitude of the fall is similar to that seen during phenytoin treatment.2 The result of the thyroid hormone binding test suggests that this effect is caused by the drug competing for binding sites. The total serum concentrations of thyroxine-binding globulin and thyroxine-binding prealbumin were not measured, but the rate of fall in total serum T4 concentration makes it unlikely that these were affected. The low serum T4 and T3 concentrations and a low normal free serum T4 concentration during long-term fenclofenac treatment have been reported.3
The rapid fall in total thyroid hormone concentrations and the blunted TRH response might have been expected to be associated with a rise in free T4 and T3 concentrations. But there was a fall in free hormone concentrations. Conceivably a short-lived peak of free T4 and T3 occurred after the first dose of fenclofenac, but this would not explain the depressed TRH response seen on day 14. The repeated administration of TRH is unlikely to be responsible for this effect.4 It appears that fenclofenac, in addition to displacing thyroxine from its binding sites, has a thyroxine-like effect on the pituitary gland causing partial inhibition of the thyrotrophin response to TRH. We conclude that care must be taken to avoid a spurious diagnosis of hypothyroidism during fenclofenac treatment. The postulated effect of fenclofenac on the pituitary gland is being investigated.
We thank Dr Alan Cassells-Smith for biochemical tests, Dr Hans 0rskov for free thyroxine assays, and Professor K G M M Alberti for helpful advice. Are reflectance meters necessary for home blood glucose monitoring?
Tattersall recently discussed the role of reflectance meters in home blood glucose monitoring.' A major factor limiting their wider use is their high cost.2 The Haemoglukotest 20-800 reagent strip (Boehringer Mannheim) offers a considerable saving in capital outlay, since it can be read by eye alone.3 We discuss its possible role in home blood glucose monitoring.
Patients, methods, and results
The Haemoglukotest is specific for glucose. It has two separate test areas, whose indicators permit differentiation of eight pairs of colours corresponding to 1-1, 2-2, 4 4, 6-7, 10-0, 13-3, 22-2, and 44-4 mmol glucose/l blood (20, 40, 80, 121-8, 181-8, 241-8, 403-6 , and 807-3 mg/100 ml).
Estimations of blood glucose concentrations (mmol/l) performed at clinic and at home with Haemoglukotest, and mean (± 95 0 confidence limits) blood glucose concentrations (mmol/l) determined by autoanalyser and reflectance meter in these test samples 3-2 ±1-1 4 8 ± 2 0 6 9±3 4 10 5±3-2 15-2±5-2 23-6±10 0
Conversion: SI to traditional units-Blood glucose: 1 mmol 18 mg/100 ml.
Random venous blood samples were taken from 32 diabetic children, 24 non-diabetic children, and three small-for-dates babies who were transiently hypoglycaemic at birth. Part of the sample was tested by the patient, his parent, or both independently using the Haemoglukotest. If the test colour did not exactly correspond to any of the eight values, the tester was asked to choose the nearest match. A total of 102 assessments were made on 59 blood samples, which were then tested in the laboratory autoanalyser by a modified glucose oxidase method.
Five diabetic patients, experienced in monitoring blood glucose concentrations at home using a Glucocheck reflectance meter (Medistron) and Dextrostix reagent strips (Ames), were asked to make an independent assessment of their blood glucose concentration at each test using the Haemoglukotest. Results of 242 pairs of tests were recorded by these five patients.
The table shows the number of tests performed in the clinic and at home corresponding to each Haemoglukotest value and the range of blood glucose concentrations (mmol/l; within 95 %/ confidence limits) of these same samples tested by the autoanalyser and Glucocheck reflectance meter respectively.
Comment
A high overall correlation was obtained between the concentrations determined with the Haemoglukotest and the mean values measured by the autoanalyser and reflectance meter (mean value determined by autoanalyser =1 + 088 x Haemoglukotest value, r -098; mean value determined by reflectance meter = 0 2 + 1 08 x Haemoglukotest value, r=0 99). The main disadvantage of the Haemoglukotest was its inability precisely to identify hypoglycaemia and hyperglycaemia at concentrations of 2-2 and 10-0 mmol/l (40 and 181 8 mg/100 ml) respectively.
The Haemoglukotest value of 2 2 mmol/l (40 mg/100 ml) corresponded to a range in blood glucose concentrations of 1 9-4 1 mmol/l (34-5-74 5 mg/100 ml; p<0 05) as measured by the autoanalyser and 2-1-4 3 mmol/l (38 2-78 2 mg/100 ml; p<005) as measured by the reflectance meter. Similarly, the Haemoglukotest value of 10-0 mmol/l (181 8 mg/100 ml) corresponded to a range of 7-14 2 mmol/l (127-3-258-2 mg/100 ml; p<0 05) and 7 3-13 7 mmol/l (132 8-249 1 mg/100 ml; p<0 05) as measured by the autoanalyser and reflectance meter respectively. This need not be a major drawback if these values are interpreted in a clinical context. The values of 13 3 and 22-2 mmol/l (241 8 and 403 6 mg/100 ml) constantly represented blood glucose concentrations in the hyperglycaemic range while that of 1 1 mmol/l (20 mg/100 ml) represented four samples all of which had concentrations under 2-2 mmol/l (40 mg/100 ml). On the other hand, the values of 4 4 and 6 7 mmol/l (80 and 121 8 mg/100 ml) almost always corresponded to blood glucose concentrations (as measured by the autoanalyser and reflectance meter) within the normal range.
The main advantages of the Haemoglukotest were simplicity and convenience. Furthermore, 25 strips cost C2 90 compared with a cost of £91-00 for a Glucocheck meter and £2 65 for 25 Dextrostix strips.
We conclude that the Haemoglukotest 20-800 offers a simple, cheap alternative method of monitoring blood glucose concentrations at home.
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